Showing results (41-50 of 107) with videos related to
Sort By:
Pageof 11
Brain Research Bulletin|September 7, 2001
Cellular and molecular aspects of striatal developmentM Jain, R J Armstrong, R A Barker, et al.Cell Transplantation|December 21, 2006
Transplanted human neural precursor cells migrate widely but show no lesion-specific tropism in the 6-hydroxydopamine rat model of Parkinson's diseaseM Jain, R J E Armstrong, S Elneil, et al.Experimental Neurology|September 1, 1996
The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatumR A Barker, S B Dunnett, A Faissner, et al.Journal of Neurology|December 28, 2020
The sleep and circadian problems of Huntington's disease: when, why and their importanceZ Voysey, S V Fazal, A S Lazar, et al.Cell Transplantation|November 1, 1996
A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures, and in vivo graftsR A Fricker, R A Barker, J W Fawcett, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 12, 1998
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidityR A Barker, T Revesz, M Thom, et al.Journal of the American College of Cardiology|July 1, 1990
Surgical intervention for drug-resistant ventricular tachycardiaR W Landymore, M A Gardner, A J McIntyre, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 25, 2000
A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's diseaseR A Barker, E Ratcliffe, M McLaughlin, et al.Neuroimage|January 9, 2010
Dynamic causal modelling of effective connectivity from fMRI: are results reproducible and sensitive to Parkinson's disease and its treatment?J B Rowe, L E Hughes, R A Barker, et al.Methods in Molecular Medicine|February 15, 2011
Neural stem cell technology as a novel treatment for Parkinson's diseaseR J Armstrong, A E Rosser, S B Dunnett, et al.Pageof 11